Magnolia Medical Technologies

Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests. It has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending.

It was incorporated in 2011 and is based in Seattle, Washington.

Magnolia Medical Technologies headquartered in United States, North America, operates in the Health Care, Medical Device, Health Diagnostics sector. The company focuses on Health Care and has secured $12.7B in funding across 108 round(s). With a team of 101-250 employees, Magnolia Medical Technologies is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Magnolia Medical Technologies, raised $2.5M. Discover more about their projects, partnerships, and impact on our platform.